Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action. Concerted
about
The potential impact of male circumcision on HIV in Sub-Saharan AfricaIncreasing clinical virulence in two decades of the Italian HIV epidemicPhylogenetic approach reveals that virus genotype largely determines HIV set-point viral loadModeling of HIV-1 infection: insights to the role of monocytes/macrophages, latently infected T4 cells, and HAART regimesTrue story about HIV: theory of viral sequestration and reserve infectionUse of surveillance data on HIV diagnoses with HIV-related symptoms to estimate the number of people living with undiagnosed HIV in need of antiretroviral therapyLack of evidence for changing virulence of HIV-1 in North America.HIV competition dynamics over sexual networks: first comer advantage conserves founder effects.Extra-couple HIV transmission in sub-Saharan Africa: a mathematical modelling study of survey data.Estimating HIV Incidence, Time to Diagnosis, and the Undiagnosed HIV Epidemic Using Routine Surveillance Data.Creating and validating an algorithm to measure AIDS mortality in the adult population using verbal autopsy.Regulatory polymorphisms in the cyclophilin A gene, PPIA, accelerate progression to AIDS.When did HIV incidence peak in Harare, Zimbabwe? Back-calculation from mortality statisticsEstimating incidence from prevalence in generalised HIV epidemics: methods and validation.Clinical prognostic value of RNA viral load and CD4 cell counts during untreated HIV-1 infection--a quantitative review.The contribution of viral genotype to plasma viral set-point in HIV infectionAntiretroviral treatment in HIV-infected infants and young children: novel issues raised by the Mississippi babyJoint estimation of CD4+ cell progression and survival in untreated individuals with HIV-1 infection.HIV-1 CRF01_AE strain is associated with faster HIV/AIDS progression in Jiangsu Province, ChinaHIV-infected former plasma donors in rural Central China: from infection to survival outcomes, 1985-2008.HIV infection in older adults in sub-Saharan Africa: extrapolating prevalence from existing data.Spectrum: a model platform for linking maternal and child survival interventions with AIDS, family planning and demographic projections.Micronutrient supplementation in adults with HIV infection.Viral genetic variation accounts for a third of variability in HIV-1 set-point viral load in Europe.Net survival of perinatally and postnatally HIV-infected children: a pooled analysis of individual data from sub-Saharan AfricaIncreased rate of CD4+ T-cell decline and faster time to antiretroviral therapy in HIV-1 subtype CRF01_AE infected seroconverters in Singapore.Low CD4+ T cell counts among African HIV-1 infected subjects with group B KIR haplotypes in the absence of specific inhibitory KIR ligands.Development and validation of decision rules to guide frequency of monitoring CD4 cell count in HIV-1 infection before starting antiretroviral therapyCopy-years viremia as a measure of cumulative human immunodeficiency virus viral burden.Genome-wide association scan in HIV-1-infected individuals identifying variants influencing disease course.Is the virulence of HIV changing? A meta-analysis of trends in prognostic markers of HIV disease progression and transmission.Immunity to HIV in Early LifeEvaluation of rapid progressors in HIV infection as an extreme phenotype.Transmission selects for HIV-1 strains of intermediate virulence: a modelling approach.Anti-retroviral treatment outcomes among older adults in Zomba district, Malawi.Modified Kigali combined staging predicts risk of mortality in HIV-infected adults in Lusaka, Zambia.The risk of AIDS-defining events is decreasing over time in the German HIV-1 Seroconverter Cohort.Coreceptor usage, diversity, and divergence in drug-naive and drug-exposed individuals from Malawi, infected with HIV-1 subtype C for more than 20 years.Effect of hormonal contraceptive use before HIV seroconversion on viral load setpoint among women in Rakai, Uganda.Estimation of HIV-testing rates to maximize early diagnosis-derived benefits at the individual and population level
P2860
Q21144704-6B1A1CB9-7722-4141-B7CC-31268685EB10Q28475522-DB0B9EF3-BE09-42A0-89B3-256FFA6AFDA0Q28475652-880CA873-D448-4719-8841-2B3B1D70B219Q28484046-ED3DB55A-A8D1-4551-B23C-6D3C936B4537Q28732833-57BB1333-D785-4100-8C40-1B09DAA23D12Q30000634-CAA8CB8C-D18C-4BA4-BCA3-84B67A85F710Q30367604-BB594C41-D8CD-40BC-ABE6-A9591DBF8CB3Q30371471-44D65B00-2097-45C6-8EB1-25F589AB90DBQ30587333-C6E84356-2E60-47E8-B43B-6C1504496045Q30982952-425FAC88-C107-428B-821D-58112F969B60Q33252476-D7A635DE-6BE8-409D-87CF-532EF220F5C9Q33288731-CAEB101F-CAFC-4A57-87BC-AFA22A9C281AQ33322515-457C16CC-8E39-451B-987A-39DA8CCF7D07Q33347813-67F488C9-1F68-4122-83C0-5E17EB09DD03Q33470290-B017AACE-8449-4626-AFCA-EF68FEEEA581Q33553778-A311FA06-EAD3-45A7-A98A-206DD3618260Q33557037-59FEC88C-6149-4672-AEF7-C0A8E0A59A65Q33631159-DE921E93-F90B-4D3E-BEA8-C27F0BF857D4Q33685740-802C81D3-8466-4EC2-B4AE-70EFC63BCBF9Q33742029-7CC11A0B-7034-4709-8134-95BA6C24ECC7Q33746432-FC3137F9-292E-4931-9874-76ED4D471720Q33754434-7FD0E69A-63C0-4866-89F1-AB0A31556456Q33761301-1A339115-3B2F-4DCA-8638-C1AB8E746DA9Q33788085-8D7AED3F-FFCB-45D9-AC56-7E282DD460E0Q33797490-8107971A-770B-4C8D-90AA-8231C1D7F06FQ33813282-1210FBFC-5F73-4B88-A596-383CFB155293Q33828392-84B22CAD-24CD-4745-B45C-D57DCE950FECQ33873614-39D2BC33-9DF1-46B6-B991-F619934E17DDQ33883560-9263965B-87F7-4EB9-AADC-E5B603F74A75Q33979751-88AD1ECC-4092-45A6-A207-A8E9FA3E0C85Q34029430-E0CF8187-0D75-49F5-900E-3420CAFD39D5Q34033051-66F6300E-FC5C-4E8F-9C03-E375B7545DA1Q34051108-0B5FFB50-77B9-4E3B-B35B-D720F60753AAQ34055207-237FFFCA-2ED7-42E7-9091-15E6A00043CAQ34059653-F66B6917-8662-4458-8A42-6D97254AAB49Q34085355-3296F375-D92E-49AD-8D53-E5F58D604AB9Q34239235-1F766D78-0523-493B-A2B1-DC4E3C8F6775Q34269253-FB60C8D2-653B-4C60-BAF8-2602AF01F478Q34500839-3E628B66-6B86-4F53-B5A2-270577AE91C4Q34544751-CE068E90-0D78-41CC-B1CA-2BA7E4ACDAA2
P2860
Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action. Concerted
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Time from HIV-1 seroconversion ...... EU Concerted Action. Concerted
@nl
type
label
Time from HIV-1 seroconversion ...... EU Concerted Action. Concerted
@nl
prefLabel
Time from HIV-1 seroconversion ...... EU Concerted Action. Concerted
@nl
P921
P1433
P1476
Time from HIV-1 seroconversion ...... on to AIDS and Death in Europe
@en
P304
P407
P577
2000-04-01T00:00:00Z